ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

NCI Advisory Group, Other Cancer Meetings

June 2, 1989

Tobacco Council awards $10 Million In 1986

August 14, 1987

Trimodality Therapy Improves Survival In Early Disease

January 27, 2006

First Oncology Nursing Certifications Exams Scheduled For April 30

November 8, 1985

In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director

March 6, 1992